Dr. Danilo R. Bernardo, MD

Dr. Bernardo practices at Bma of Roanoke Rapids in Roanoke Rapids, North Carolina.

Dr. Bernardo's NPI, 1669409835, was assigned on June 26, 2006. Dr. Bernardo holds North Carolina license 33209.

Dr. Bernardo's primary practice is Bma of Roanoke Rapids, at 937 Gregory Dr, Roanoke Rapids, NC 27870 in Halifax County. The practice phone is (252) 535-1000.

Dr. Bernardo's primary practice is Bma of Roanoke Rapids in Roanoke Rapids, North Carolina. The medical group on file is Valley Hypertension Nephrology. Dmand AI also links Dr. Bernardo to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernardo practices. Vendor and product names are available with a free account.

Nephrology is Dr. Bernardo's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bernardo is licensed in North Carolina.

CMS data shows 155 Medicare services from Dr. Bernardo across 2 procedure codes in 2024, for 61 Medicare patients. Medicare paid $43,083 for them. Every service was in an office.

CMS counts 61 Medicare patients who saw Dr. Bernardo in 2024. The largest group is under 65, with 22 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 39% are also on Medicaid. Their average risk score is 8.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bernardo's median patient age at 68, with 67% women.

In 2024, Dr. Bernardo wrote 1,819 Medicare Part D claims for 269 patients. 79% of them were for generic drugs. CMS names the drug for 1,507 of them, across 42 drugs with 11 or more claims each, at $498,218 in total drug cost. In 2023, CMS named 3,848 claims across 76 drugs.

Dmand AI links 3 papers to Dr. Bernardo, published from 2018 to 2025. Dr. Bernardo's most frequent co-authors are Kurtis Ian Auguste, MD, Ernesto Gonzalez-Giraldo, MD and Shaun Alexander Hussain, MD, MS.

Dmand AI links Dr. Bernardo to 1 clinical trial. Conditions studied include Epilepsy, Absence and Epilepsy, Generalized.

CMS Open Payments shows 230 general payments to Dr. Bernardo from 28 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 92% of the total. OPKO Pharmaceuticals, LLC paid the most, $526.